Arbutus Biopharma Corporation ABUS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $169.7M+4,618% | -$3.76M+51.5% | -$7.74M-407% | $2.52M+110% | -$24.53M-95.7% | ||
| $11K0.0% | $11K0.0% | $11K0.0% | $11K-96.7% | $330K-0.9% | ||
| $1.36M+7.7% | $1.26M-0.1% | $1.26M+46.2% | $864K-75.8% | $3.56M+118% | ||
| -$8.11M-73.3% | -$4.68M+19.5% | -$5.82M+63.1% | -$15.75M-17.6% | -$13.39M-29.8% | ||
| $2.2M— | —— | —— | $15.61M+37.6% | $11.35M-15.4% | ||
| $11.62M+608% | $1.64M+94.3% | $844K+86.3% | $453K-83.7% | $2.78M+95.9% | ||
| $5.7M+230% | -$4.4M+70.7% | -$15M-4,565% | $336K-55.0% | $746K-83.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Arbutus Biopharma Corporation generate?
- Arbutus Biopharma Corporation (ABUS) generated -$34.4M in operating cash flow over the trailing twelve months.
- Where does Arbutus Biopharma Corporation's cash flow data come from?
- Every line is extracted from Arbutus Biopharma Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
